NLS Pharmaceutics Ltd (NLSP)
0.1483
+0.03
(+30.18%)
USD |
NASDAQ |
Jun 17, 16:00
0.4013
+0.25
(+170.60%)
After-Hours: 07:39
NLS Pharmaceutics 30-Day Average Daily Volume: 1.488M for June 17, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| June 17, 2024 | 1.488M |
| June 14, 2024 | 1.067M |
| June 13, 2024 | 1.056M |
| June 12, 2024 | 1.045M |
| June 11, 2024 | 1.030M |
| June 10, 2024 | 954554.7 |
| June 07, 2024 | 955368.8 |
| June 06, 2024 | 951642.3 |
| June 05, 2024 | 946392.0 |
| June 04, 2024 | 947076.1 |
| June 03, 2024 | 956447.9 |
| May 31, 2024 | 944726.9 |
| May 30, 2024 | 909578.0 |
| May 29, 2024 | 889451.8 |
| May 28, 2024 | 854466.8 |
| May 24, 2024 | 691443.2 |
| May 23, 2024 | 364530.5 |
| May 22, 2024 | 315837.5 |
| May 21, 2024 | 305801.9 |
| May 20, 2024 | 280504.4 |
| May 17, 2024 | 236387.2 |
| May 16, 2024 | 231640.3 |
| May 15, 2024 | 198311.4 |
| May 14, 2024 | 211348.5 |
| May 13, 2024 | 213665.8 |
| Date | Value |
|---|---|
| May 10, 2024 | 218245.9 |
| May 09, 2024 | 239938.4 |
| May 08, 2024 | 249381.6 |
| May 07, 2024 | 262306.3 |
| May 06, 2024 | 301222.1 |
| May 03, 2024 | 332141.9 |
| May 02, 2024 | 465931.2 |
| May 01, 2024 | 1.158M |
| April 30, 2024 | 1.157M |
| April 29, 2024 | 1.174M |
| April 26, 2024 | 1.175M |
| April 25, 2024 | 1.162M |
| April 24, 2024 | 1.160M |
| April 23, 2024 | 1.164M |
| April 22, 2024 | 1.155M |
| April 19, 2024 | 1.138M |
| April 18, 2024 | 1.137M |
| April 17, 2024 | 1.135M |
| April 16, 2024 | 1.134M |
| April 15, 2024 | 1.125M |
| April 12, 2024 | 1.122M |
| April 11, 2024 | 1.116M |
| April 10, 2024 | 1.104M |
| April 09, 2024 | 1.101M |
| April 08, 2024 | 1.099M |
30-Day Average Daily Volume Range, Past 5 Years
28933.60
Minimum
Jun 14 2023
7.740M
Maximum
Jan 11 2022
807858.0
Average
232154.6
Median
30-Day Average Daily Volume Benchmarks
| AC Immune SA | 1.555M |
| CRISPR Therapeutics AG | 1.352M |
| Addex Therapeutics Ltd | 4886.87 |
| Molecular Partners AG | 29554.27 |
| MoonLake Immunotherapeutics | 307303.7 |